<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rospedj</journal-id><journal-title-group><journal-title xml:lang="ru">Российский педиатрический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Pediatric Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2687-0843</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15690/rpj.v1i2.2089</article-id><article-id custom-type="elpub" pub-id-type="custom">rospedj-44</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Оценка физического развития и здоровья детей, зачатых при помощи ВРТ, имеющих ретинопатию недоношенных: популяционное одномоментное исследование</article-title><trans-title-group xml:lang="en"><trans-title>Evaluation of physical development and state of health in ART-conceived children with retinopathy of prematurity: a population, one-time study</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3119-478X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Плаксина</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Plaksina</surname><given-names>Anna N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Плаксина Анна Николаевна, кандидат медицинских наук, ассистент кафедры физической и реабилитационной медицины, заведующая детской поликлиникой ООО «Европейский медицинский центр «УГМК-Здоровье»</p><p>620028, обл. Свердловская, г. Екатеринбург, ул. Репина, д. 3</p></bio><bio xml:lang="en"><p>Ekaterinburg</p></bio><email xlink:type="simple">burberry20@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4462-4179</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ковтун</surname><given-names>О. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kovtun</surname><given-names>Olga P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>620028, обл. Свердловская, г. Екатеринбург, ул. Репина, д. 3</p></bio><bio xml:lang="en"><p>Ekaterinburg</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0333-0043</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Степанова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Stepanova</surname><given-names>Elena A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>620028, обл. Свердловская, г. Екатеринбург, ул. Репина, д. 3</p></bio><bio xml:lang="en"><p>Ekaterinburg</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2502-2092</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дугина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dugina</surname><given-names>Elena A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Екатеринбург</p></bio><bio xml:lang="en"><p>Ekaterinburg</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1127-2792</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макутина</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Makutina</surname><given-names>Valeriya A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Екатеринбург</p></bio><bio xml:lang="en"><p>Ekaterinburg</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4318-5223</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Синотова</surname><given-names>С. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Sinotova</surname><given-names>Svetlana L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Екатеринбург</p></bio><bio xml:lang="en"><p>Ekaterinburg</p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2084-3916</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лимановская</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Limanovskaya</surname><given-names>Oksana V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Екатеринбург</p></bio><bio xml:lang="en"><p>Ekaterinburg</p></bio><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budget Educational Institution of Higher Education «Ural State Medical University» of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации;&#13;
Государственное автономное учреждение здравоохранения Свердловской области «Многопрофильный клинический медицинский центр «Бонум»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budget Educational Institution of Higher Education «Ural State Medical University» of the Ministry of Health of the Russian Federation;&#13;
State Autonomous Healthcare Institution of the Sverdlovsk region «Multidisciplinary Clinical Medical Center «Bonum»</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Государственное автономное учреждение здравоохранения Свердловской области «Многопрофильный клинический медицинский центр «Бонум»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>State Autonomous Healthcare Institution of the Sverdlovsk region «Multidisciplinary Clinical Medical Center «Bonum»</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Акционерное общество «Центр семейной медицины»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Joint stock company «Center of Family Medicine»</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Федеральное государственное автономное образовательное учреждение высшего образования «Уральский федеральный университет имени первого Президента России Б. Н. Ельцина»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Autonomous Educational Institution of Higher Education «Ural Federal University named after the first President of Russia B.N. Eltsin»</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>28</day><month>04</month><year>2020</year></pub-date><volume>1</volume><issue>2</issue><fpage>18</fpage><lpage>24</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Плаксина А.Н., Ковтун О.П., Степанова Е.А., Дугина Е.А., Макутина В.А., Синотова С.Л., Лимановская О.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Плаксина А.Н., Ковтун О.П., Степанова Е.А., Дугина Е.А., Макутина В.А., Синотова С.Л., Лимановская О.В.</copyright-holder><copyright-holder xml:lang="en">Plaksina A.N., Kovtun O.P., Stepanova E.A., Dugina E.A., Makutina V.A., Sinotova S.L., Limanovskaya O.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rospedj.ru/jour/article/view/44">https://www.rospedj.ru/jour/article/view/44</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. Вспомогательные репродуктивные технологии (ВРТ) ассоциированы с преждевременным рождением детей. Женщины, прибегнувшие к ВРТ, c высоким индексом массы тела (ИМТ) имеют повышение инсулиноподобного фактора роста‑1 (ИФР‑1), участвующего в развитии патологической вазопролиферации при ретинопатии недоношенных (РН). Дети с РН являются группой риска по наличию коморбидной патологии.</p></sec><sec><title>Цель исследования</title><p>Цель исследования. Оценка физического развития и состояния здоровья детей с РН, зачатых при помощи ВРТ.</p></sec><sec><title>Методы</title><p>Методы. Популяционное одномоментное исследование физического развития и состояния здоровья детей с РН. Статистический анализ проводился с помощью пакета программ SPSS v. 14.0 с определением нормальности (критерий Шапиро — Уилка), описательной статистики (М — средняя, σ — стандартное отклонение средней), непараметрических методов (критерий Манна — Уитни, Z-критерий для доли).</p></sec><sec><title>Результаты</title><p>Результаты. Антропометрические характеристики младенцев с РН не отличались от таковых у детей, зачатых спонтанно. Дети с РН, рожденные от матерей с высоким ИМТ, имели меньшие антропометрические параметры (p &lt; 0,001), дольше по времени состояли на динамическом наблюдении с диагнозом «группа риска по РН». У младенцев с РН, зачатых при помощи ВРТ, выявлено достоверное преобладание 65 диагнозов. Статистически значимо диагностировались (p = 0,0047) низкорослость и ожирение, несмотря на отсутствие отличий в антропометрических показателях при рождении (p = 0,123).</p></sec><sec><title>Заключение</title><p>Заключение. Дети, зачатые при помощи ВРТ, с РН при рождении не отличаются по физическому развитию от младенцев популяционной когорты, однако в катамнезе достоверно чаще имеют низкорослость и ожирение. Дети от матерей с высоким ИМТ имеют достоверно меньшие показатели массы и длины тела, а также дольше состоят на учете с диагнозом РН. Младенцы, зачатые при помощи ВРТ, имеющие РН, достоверно чаще имеют коморбидную патологию, чем контрольная группа детей с РН.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Assisted reproductive technology (ART) poses an increased risk for preterm birth. Women with high body mass index, who opted for ART, have the elevated levels of the insulin-like growth factor 1 (IGF-1) which is involved in the development of pathologic vasoproliferation in retinopathy of prematurity (ROP). Children with ROP are at increased risk for co-morbid pathology.</p></sec><sec><title>Objective</title><p>Objective. The study aims at evaluating physical development and state of health in ART-conceived children with ROP.</p></sec><sec><title>Methods</title><p>Methods. This is a population, one-time study to evaluate physical development and state of health in children with ROP. Statistical analysis was carried out using the SPSS v. 14.0 software package, and included determination of normality (Shapiro-Wilk test), descriptive statistics (М — mean value, σ — standard deviation of the mean), and non-parametric methods (Mann-Whitney U-test, Z-test of a proportion).</p></sec><sec><title>Results</title><p>Results. The anthropometric characteristics of infants with ROP did not differ from those in spontaneously conceived babies. Children with ROP born to mothers with high BMI had lower anthropometric parameters (p &lt; 0.001) and required longer dynamic follow-up while being diagnosed as “risk group for ROP”. A significantly higher number (a total of 65) of nosologies has been revealed in the ART-conceived infants. Statistically significant predominant diagnoses (p = 0.0047) included dwarfism and obesity despite the absence of anthropometric differences at birth (p = 0.123).</p></sec><sec><title>Conclusion</title><p>Conclusion. The ART-conceived infants with ROP at birth do not differ in their physical development from infants in the general population, however, on prospective follow-up the former developed dwarfism and obesity significantly more often. Children born to mothers with high BMI have significantly lower parameters of weight and height, and require longer follow-up period while being diagnosed with ROP. The ART-conceived infants with ROP have co-morbid pathology significantly more often than children with ROP in the control group.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ретинопатия недоношенных</kwd><kwd>вспомогательные репродуктивные технологии</kwd><kwd>шкалы Fenton и INTERGROWTH‑21</kwd><kwd>недостаточность питания</kwd></kwd-group><kwd-group xml:lang="en"><kwd>retinopathy of prematurity</kwd><kwd>assisted reproductive technology</kwd><kwd>Fenton and INTERGROWTH-21 scales</kwd><kwd>malnutrition</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено при финансовой поддержке РФФИ в рамках научного проекта № 19-37-90121.</funding-statement><funding-statement xml:lang="en">Financial support was provided by the Russian Foundation for Basic Research within the frame of research project No. 19-37-90121.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Shah P.K., Prabhu V., Karandikar S. S., et al. Retinopathy of prematurity: past, present and future. World J Clin Pediatr. 2016;5(1):35–46. doi: 10.5409/wjcp.v5.i1.35.</mixed-citation><mixed-citation xml:lang="en">Shah P.K., Prabhu V., Karandikar S. S., et al. Retinopathy of prematurity: past, present and future. World J Clin Pediatr. 2016;5(1):35–46. doi: 10.5409/wjcp.v5.i1.35.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Nuyt A.M., Lavoie J. C., Mohamed I., et al. Adult Consequences of Extremely Preterm Birth. Clin Perinatol. 2017;44(2):315–332. doi: 10.1016/j.clp.2017.01.010.</mixed-citation><mixed-citation xml:lang="en">Nuyt A.M., Lavoie J. C., Mohamed I., et al. Adult Consequences of Extremely Preterm Birth. Clin Perinatol. 2017;44(2):315–332. doi: 10.1016/j.clp.2017.01.010.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ковтун О.П., Плаксина А. Н., Макутина В. А. и др. Информационно- аналитические системы для оценки перинатальных исходов и состояния здоровья детей, рожденных при помощи вспомогательных репродуктивных технологий // Российский вестник перинатологии и педиатрии.— 2020. — Т. 65, № 1. — С. 45–50. doi: 10.21508/1027-4065-2020-65-1-45-50.</mixed-citation><mixed-citation xml:lang="en">Kovtun O. P., Plaksina A. N., Makutina V. A., Ankudinov N. O., Zil'ber N.A., Limanovskaya O. V., Sinotova S. L. Information-analytical systems for assessing perinatal outcomes and the health status of children who were born by assisted reproductive technologies Russian Bulletin of perinatology and pediatrics. Rossiyskiy vestnik perinatologii i pediatrii. 2020;65(1):45–50. (In Russ). doi: 10.21508/1027-4065-2020-65-1-45-50.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Luke B. Adverse effects of female obesity and interaction with race on reproductive potential. Fertil Steril. 2017;107(4):868–877. doi: 10.1016/j.fertnstert.2017.02.114.</mixed-citation><mixed-citation xml:lang="en">Luke B. Adverse effects of female obesity and interaction with race on reproductive potential. Fertil Steril. 2017;107(4):868–877. doi: 10.1016/j.fertnstert.2017.02.114.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sermondade N., Huberlant S., Bourhis-Lefebvre V., et al. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(4):439–451. doi: 10.1093/humupd/dmz01.</mixed-citation><mixed-citation xml:lang="en">Sermondade N., Huberlant S., Bourhis-Lefebvre V., et al. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(4):439–451. doi: 10.1093/humupd/dmz01.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chi M.M., Schlein A. L., Moley K. H. High insulin-like growth factor 1 (IGF‑1) and insulin concentrations trigger apoptosis in the mouse blastocyst via down-regulation of the IGF‑1 receptor. Endocrinology. 2000;141(12):4784–4792.</mixed-citation><mixed-citation xml:lang="en">Chi M.M., Schlein A. L., Moley K. H. High insulin-like growth factor 1 (IGF‑1) and insulin concentrations trigger apoptosis in the mouse blastocyst via down-regulation of the IGF‑1 receptor. Endocrinology. 2000;141(12):4784–4792.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Koning A.M., Mutsaerts М. А., Kuchenbecker W. K., et al. Complications and outcome of ART in overweight and obese women. Hum Reprod. 2012;27(2):457–467.</mixed-citation><mixed-citation xml:lang="en">Koning A.M., Mutsaerts М. А., Kuchenbecker W. K., et al. Complications and outcome of ART in overweight and obese women. Hum Reprod. 2012;27(2):457–467.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J., Liu H.1, Mao X., et al. Effect of body mass index on pregnancy outcomes in a freeze-all policy: an analysis of 22,043 first autologous frozen-thawed embryo transfer cycles in China. BMC Med. 2019;17(1):114. doi: 10.1186/s12916-019-1354-1.</mixed-citation><mixed-citation xml:lang="en">Zhang J., Liu H.1, Mao X., et al. Effect of body mass index on pregnancy outcomes in a freeze-all policy: an analysis of 22,043 first autologous frozen-thawed embryo transfer cycles in China. BMC Med. 2019;17(1):114. doi: 10.1186/s12916-019-1354-1.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu Y., Yan H., Tang M., et al. Impact of maternal prepregnancy body mass index on cognitive and metabolic profiles of singletons born after in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2019;112(6):1094–1102. doi: 10.1016/j.fertnstert.2019.08.054.</mixed-citation><mixed-citation xml:lang="en">Zhu Y., Yan H., Tang M., et al. Impact of maternal prepregnancy body mass index on cognitive and metabolic profiles of singletons born after in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2019;112(6):1094–1102. doi: 10.1016/j.fertnstert.2019.08.054.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Молчанова Е. В. Селективный скрининг по выявлению офтальмопатии у доношенных новорожденных: Дисс. … канд. мед. наук. — М., 2008. — С. 53</mixed-citation><mixed-citation xml:lang="en">Molchanova E. V. Selective screening for detection of ophthalmopathy in full-term newborns: [dissertation] Moscow; 2008. 53 p. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Катаргина Л.А., Осипова Н. А. Роль различных регуляторных факторов в патологической вазопролиферации при ретинопатии недоношенных // Российская педиатрическая офтальмология.— 2017. — Т. 12, № 3. — С. 145–152. doi: http://dx.doi.org/10.18821/1993-1859-2017-12-3-145-152.</mixed-citation><mixed-citation xml:lang="en">Katargina L. A., Osipova N. A. The role of various regulatory factors in pathological vasoproliferation in retinopathy of prematurity. Russian pediatric ophthalmology [Rossiyskaya pediatricheskaya oftal’mologiya]. 2017;12(3): 145–152. (In Russ). doi: http://dx.doi.org/10.18821/1993-1859-2017-12-3-145-152.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Nimptscha K., Konigorskia S., Pischon T. Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. Metabolism. 2019;92:61–70. doi: 10.1016/j.metabol.2018.12.006.</mixed-citation><mixed-citation xml:lang="en">Nimptscha K., Konigorskia S., Pischon T. Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. Metabolism. 2019;92:61–70. doi: 10.1016/j.metabol.2018.12.006.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kistner A., Sigurdsson J., Niklasson A., et al. Neonatal IGF‑1/ IGFBP‑1axis and retinopathy of prematurity are associated with increased blood pressure in preterm children. Acta Paediatr. 2014;103(2):149–156. doi: 10.1111/apa.12478.</mixed-citation><mixed-citation xml:lang="en">Kistner A., Sigurdsson J., Niklasson A., et al. Neonatal IGF‑1/ IGFBP‑1axis and retinopathy of prematurity are associated with increased blood pressure in preterm children. Acta Paediatr. 2014;103(2):149–156. doi: 10.1111/apa.12478.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lofqvist C., Hansen-Pupp I., Andersson E., et al. Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I. Arch Ophthalmol. 2009;127:622–627. doi: 10.1001/archophthalmol.2009.69.</mixed-citation><mixed-citation xml:lang="en">Lofqvist C., Hansen-Pupp I., Andersson E., et al. Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I. Arch Ophthalmol. 2009;127:622–627. doi: 10.1001/archophthalmol.2009.69.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hellström A., Ley D., Hansen-Pupp I., et al. IGF-I in the clinics: Use in retinopathy of prematurity. Growth Horm IGF Res. 2016;30–31: 75–80. doi: 10.1016/j.ghir.2016.09.005.</mixed-citation><mixed-citation xml:lang="en">Hellström A., Ley D., Hansen-Pupp I., et al. IGF-I in the clinics: Use in retinopathy of prematurity. Growth Horm IGF Res. 2016;30–31: 75–80. doi: 10.1016/j.ghir.2016.09.005.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lazaraviciute G., Kauser M., Bhattacharya S., et al. A systematic review and meta-analysis of DNA methylation levels and imprinting disorders in children conceived by IVF/ICSI compared with children conceived spontaneously. Hum Reprod Update. 2014;20(6):840– 852. doi: 10.1093/humupd/dmu033.</mixed-citation><mixed-citation xml:lang="en">Lazaraviciute G., Kauser M., Bhattacharya S., et al. A systematic review and meta-analysis of DNA methylation levels and imprinting disorders in children conceived by IVF/ICSI compared with children conceived spontaneously. Hum Reprod Update. 2014;20(6):840– 852. doi: 10.1093/humupd/dmu033.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE. Hum Reprod 2017;32(10):1957–1973. doi: 10.1093/humrep/dex264.</mixed-citation><mixed-citation xml:lang="en">Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE. Hum Reprod 2017;32(10):1957–1973. doi: 10.1093/humrep/dex264.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Отчет Российской ассоциации репродукции человека Доступно по: http://www.rahr.ru/registr_otchet.php. Ссылка активна на 02.04.2020.</mixed-citation><mixed-citation xml:lang="en">Report of the Russian Association of Human Reproduction (In Russ). Доступно по: http://www.rahr.ru/registr_otchet.php. Ссылка активна на 02.04.2020.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Luke B. Adverse effects of female obesity and interaction with race on reproductive potential. Fertil Steril. 2017;107(4):868–877. doi: 10.1016/j.fertnstert.2017.02.114.</mixed-citation><mixed-citation xml:lang="en">Luke B. Adverse effects of female obesity and interaction with race on reproductive potential. Fertil Steril. 2017;107(4):868–877. doi: 10.1016/j.fertnstert.2017.02.114.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Питание с учетом скорректированного возраста / А. Н. Плаксина, Ю. В. Марчук, Е. А. Дугина; Государственное учреждение здравоохранения детская клиническая больница восстановительного лечения «Научно-практический центр «Бонум». — Свидетельство об официальной регистрации программы для ЭВМ № 2017662949 от 21.11.2017.</mixed-citation><mixed-citation xml:lang="en">Age-adjusted nutrition/ A. N. Plaksina, Yu. V. Marchuk, E. A. Dugina; Gosudarstvennoe uchrezhdenie zdravookhraneniya detskaya klinicheskaya bol'nitsa vosstanovitel'nogo lecheniya «Nauchno-prakticheskiy tsentr «Bonum». — Svidetel’stvo ob ofitsial’noy registratsii programmy dlya EVM № 2017662949 ot 21.11.2017. (In Russ).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
